All News

Top news of the day from across the health care landscape.

Rizaport is an oral film formulation of rizatriptan benzoate, the active drug in Maxalt, for patients with migraine who experience dysphagia or migraine-related nausea.

The hearing will take place May 13, 2019 at the agency’s headquarters in Silver Spring, Maryland.

Melatoin is an antioxidant and stimulates growth receptors in the skin and hair.

Voluntary reports indicate that some individuals, especially youth and young adults, are experiencing seizures or convulsions following use of e-cigarettes, although a definitive link has not been established.

The daratumumab (Darzalex) combination therapy would be the first for use in the frontline setting for transplant-eligible patients with multiple myeloma.

Top news of the day from across the health care landscape.

HIV infection is associated with higher rates of hepatitis C replication.

If approved, Gimoti would be the first non-oral drug treatment for symptoms associated with acute and recurrent diabetic gastroparesis in adult women and would represent the first significant advancement in the treatment of gastroparesis in 40 years.

Immune Globulin Intravenous, Human – slra 10% Liquid (Asceniv) is indicated for use in the treatment of primary humoral immunodeficiency disease in adults and adolescents.

Although lung cancer screenings are covered at no cost by most insurers, state Medicaid programs are not required to offer coverage for this service.

Immune Globulin Intravenous, Human – slra 10% Liquid (Asceniv) is indicated for use in the treatment of primary humoral immunodeficiency disease in adults and adolescents.

Top news of the day from across the health care industry.

The combination treatment (Duaklir, Circassia) is designed to be administered twice-daily via AstraZeneca’s breath-actuated inhaler (Pressair).

The combination therapy was approved for twice-daily administration via the breath-actuated Pressair inhaler in patients with COPD.

Avaclyr 3%, a herpes simplex virus nucleoside analog DNA polymerase inhibitor.

In addition to concerns about contamination, some products made by these companies that are labeled as homeopathic do not deliver any benefit, yet may potentially be harmful, according to the FDA.

Gilteritinib (Xospata) was superior to standard chemotherapy in improving overall survival in patients with acute myeloid leukemia.

Why did this patient's warfarin dose triple?

Top news of the day from across the health care industry.

Benzodiazepines are involved in over 30% of opioid overdoses. It is important to learn about this combination and how to counsel patients.

The IAVI WOO1 study is one of the first clinical trials of a native-like Env trimer and the first time that this particular trimer is being evaluated in humans

This article will describe the unusual discovery of 5 commonly prescribed medications, many of which were through serendipitous events.

Cladribine (Mavenclad, EMD Serono) is the first oral multiple sclerosis drug to demonstrate 2 years of proven efficacy with a maximum of 20 days of treatment.

Cladribine (Mavenclad, EMD Serono) is the first oral multiple sclerosis drug to demonstrate 2 years of proven efficacy with a maximum of 20 days of treatment.

Study data suggest the drug helps reduce the risk of major adverse cardiovascular event in certain patients.